A Multivalent and Cross-Protective Vaccine Strategy against Arenaviruses Associated with Human Disease

• Maya F. Kotturi,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Jason Botten,

  Affiliation Vermont Center for Immunology and Infectious Diseases, The University of Vermont College of Medicine, Burlington, Vermont, United States of America

  ⨯
• John Sidney,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Huynh-Hoa Bui,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Lori Giancola,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Matt Maybeno,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Josie Babin,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Carla Oseroff,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Valerie Pasquetto,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Jason A. Greenbaum,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Bjoern Peters,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Joey Ting,

  Affiliation Departments of Molecular Biology and Biochemistry and Community and Environmental Medicine, University of California, Irvine, California, United States of America

  ⨯
• Danh Do,

  Affiliation Vermont Center for Immunology and Infectious Diseases, The University of Vermont College of Medicine, Burlington, Vermont, United States of America

  ⨯
• Lo Vang,

  Current address: PaxVax, Inc., San Diego, California, United States of America

  Affiliation Pharmexa-Epimmune, San Diego, California, United States of America

  ⨯
• Jeff Alexander,

  Current address: PaxVax, Inc., San Diego, California, United States of America

  Affiliation Pharmexa-Epimmune, San Diego, California, United States of America

  ⨯
• Howard Grey,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Michael J. Buchmeier,

  Affiliation Departments of Molecular Biology and Biochemistry and Community and Environmental Medicine, University of California, Irvine, California, United States of America

  ⨯
•  [ ... ],
• Alessandro Sette

  * E-mail: alex@liai.org

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• [ view all ]
• [ view less ]